ARCHIVES

Clinical Trials: Phase I Trial of Karenitecin Begins, BioNumerik Says

This article is from The Cancer Letter archive.

Vol. 25 No. 09 | March 5, 1999

Download PDF Visit The Full Archive

Related Articles

Guest Editorial: Richard Schilsky Reflects On His Past Decade WithThe Board of Scientific Advisors

June 24, 2011

NCI Drops Breast Screening Guidelines, Issues “Summary Of Scientific Fact”

December 10, 1993

Conversation With The Cancer Letter: Seffrin To Retire After Restructuring ACS

January 24, 2014

Hamburg Confirmed As FDA Commissioner

May 22, 2009

New Risk Stratification Method For Prostate Cancer Described

November 28, 2003

Workshop Calls For Improved Surgical Oncology Training Programs

December 2, 1983